These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 22457198

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of Sclerostin Antibody on the Healing of Femoral Fractures in Ovariectomised Rats.
    Liu Y, Rui Y, Cheng TY, Huang S, Xu L, Meng F, Lee WY, Zhang T, Li N, Li C, Ke H, Li G.
    Calcif Tissue Int; 2016 Mar; 98(3):263-74. PubMed ID: 26603303
    [Abstract] [Full Text] [Related]

  • 4. Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody.
    Li X, Niu QT, Warmington KS, Asuncion FJ, Dwyer D, Grisanti M, Han CY, Stolina M, Eschenberg MJ, Kostenuik PJ, Simonet WS, Ominsky MS, Ke HZ.
    Endocrinology; 2014 Dec; 155(12):4785-97. PubMed ID: 25259718
    [Abstract] [Full Text] [Related]

  • 5. Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse.
    Zhang D, Hu M, Chu T, Lin L, Wang J, Li X, Ke HZ, Qin YX.
    Bone; 2016 Jun; 87():161-8. PubMed ID: 26868528
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effects of sclerostin antibody plus parathyroid hormone (1-34) on bone formation in ovariectomized rats.
    Wu J, Cai XH, Qin XX, Liu YX.
    Z Gerontol Geriatr; 2018 Jul; 51(5):550-556. PubMed ID: 28364259
    [Abstract] [Full Text] [Related]

  • 8. Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis.
    Chen H, Xu X, Liu M, Zhang W, Ke HZ, Qin A, Tang T, Lu E.
    Bone; 2015 Jul; 76():141-8. PubMed ID: 25868799
    [Abstract] [Full Text] [Related]

  • 9. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
    Li X, Ominsky MS, Warmington KS, Niu QT, Asuncion FJ, Barrero M, Dwyer D, Grisanti M, Stolina M, Kostenuik PJ, Simonet WS, Paszty C, Ke HZ.
    Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in rats.
    Suen PK, He YX, Chow DH, Huang L, Li C, Ke HZ, Ominsky MS, Qin L.
    J Orthop Res; 2014 Aug; 32(8):997-1005. PubMed ID: 24782158
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sclerostin-Neutralizing Antibody Enhances Bone Regeneration Around Oral Implants.
    Yu SH, Hao J, Fretwurst T, Liu M, Kostenuik P, Giannobile WV, Jin Q.
    Tissue Eng Part A; 2018 Nov; 24(21-22):1672-1679. PubMed ID: 29921173
    [Abstract] [Full Text] [Related]

  • 16. Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody.
    Ominsky MS, Niu QT, Li C, Li X, Ke HZ.
    J Bone Miner Res; 2014 Jun; 29(6):1424-30. PubMed ID: 24967455
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sclerostin antibody enhances bone formation in a rat model of distraction osteogenesis.
    McDonald MM, Morse A, Birke O, Yu NYC, Mikulec K, Peacock L, Schindeler A, Liu M, Ke HZ, Little DG.
    J Orthop Res; 2018 Apr; 36(4):1106-1113. PubMed ID: 28884841
    [Abstract] [Full Text] [Related]

  • 19. Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model.
    Tian X, Jee WS, Li X, Paszty C, Ke HZ.
    Bone; 2011 Feb; 48(2):197-201. PubMed ID: 20850580
    [Abstract] [Full Text] [Related]

  • 20. Time course of disassociation of bone formation signals with bone mass and bone strength in sclerostin antibody treated ovariectomized rats.
    Ma YL, Hamang M, Lucchesi J, Bivi N, Zeng Q, Adrian MD, Raines SE, Li J, Kuhstoss SA, Obungu V, Bryant HU, Krishnan V.
    Bone; 2017 Apr; 97():20-28. PubMed ID: 27939957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.